Kimihiko Ito

4PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 17, 2025
Prognostic factors for malignant tumors arising from mature cystic teratomas: a study involving the Kansai Clinical Oncology Group (KCOG-G1305s study).

Fuminori Ito, Mototsugu Shimokawa, Atsushi Sugiura

|Oct 25, 2024
Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer.

Mika Okazawa-Sakai, Shunsuke A Sakai, Ichinosuke Hyodo

|Sep 02, 2021
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).

Junzo Hamanishi, Nobuhiro Takeshima, Noriyuki Katsumata

Pageof 1